xCures: Funding, Investors & Team (Oct 2026)
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, with an AI-based precision oncology platform that tightly integrates cancer research and care. The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.
xCures has raised $58.7M across 2 funding rounds on record, the most recent a Series B of $46.0M announced in Jun 2026.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
xCures Company Profile and Key Stats
Latest funding round on record: Jun 2026.
xCures Funding Rounds
xCures raised $12.7M in an undisclosed round announced in Jun 2021.
5 years later, a Series B of $46.0M was announced in Jun 2026.
xCures Founders and Leadership Team
No contact details are on record for this team yet.
xCures Funding Compared to Other Artificial Intelligence Startups
xCures' latest round of $46.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like xCures in Artificial Intelligence and Los Altos
Companies Similar to xCures
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
xCures Funding FAQs
What does xCures do?
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, with an AI-based precision oncology platform that tightly integrates cancer research and care. The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.
How much funding has xCures raised?
xCures has raised $58.7M across 2 rounds on record. The most recent is a Series B of $46.0M announced in Jun 2026.
When did xCures last raise funding?
xCures' most recent funding round on record is a Series B of $46.0M, announced in Jun 2026.
Who is the CEO of xCures?
Mika Newton is listed as CEO at xCures.
Where is xCures headquartered?
xCures is based in Los Altos, California, United States.
How many employees does xCures have?
xCures is in the 11-50 employee band.
How does xCures' funding compare to other Artificial Intelligence startups?
xCures' latest round of $46.0M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's xCures Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for xCures is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.